Fusion VC
730 Arizona Avenue Suite 206, Santa Monica, California, 90401, United States
Overview
Fusion is Israel's leading pre-seed platform - Backed by top-tier global VC firms and 70+ serial founders. We invest $150,000 in your vision - and work closely with you to hire talent, get customers, and raise your next funding round. We produce twice a year a 10-week intensive bootcamp in Tel Aviv, Silicon Valley, New York and Los Angeles. You'll participate in 150+ sessions presented by serial founders, investors, and mentors to set your company on a strong foundation. We are actively looking for Israeli early-stage companies to join our family and scale in the US market. Read more: https://www.fusion-vc.com/
- Total investments
- 13
- Lead investments
- 1
- Investments · 12mo
- 5
- Active investors
- 4
Sector focus
- Business Development
- Venture Capital
Investment portfolio
- Skapion
Participated · Seed · Jul 2026
Skapion develops a mobile, native counter-swarm air-defense platform designed to detect, engage and neutralize drone swarms in communications-limited and contested environments. The company emphasizes scalability and cost-efficiency to address the economics of mass UAV attacks that overwhelm traditional air-defense architectures. Its team includes former senior air-defense leaders and entrepreneurs, and Skapion has grown to several dozen employees with plans to recruit additional engineers and specialists. The startup is headquartered in Washington, D.C., with an R&D center in Ramat Gan, Israel. With the new Seed financing, Skapion intends to accelerate engineering development, perform system validation and increase engagement with governments and defense partners. The company positions itself to support maneuvering military forces, fixed installations and critical infrastructure against coordinated drone threats.
- Feminai
Participated · Seed · Jan 2026
Feminai is an Israeli health-tech startup building a wearable sensor patch that continuously monitors breast tissue density and blood-flow patterns, then analyzes the data with proprietary AI algorithms to detect early signs of breast cancer. The company’s first in-human clinical trial at Sheba Medical Center reported 96% sensitivity and a 98% negative predictive value, indicating strong diagnostic accuracy. Co-founded by physician-CEO Dr. Karny Ilan along with Gal Yanuka and Shani Klein, Feminai aims to replace or supplement clinic-based imaging with a more accessible, affordable, and user-friendly home solution. The recent seed funding equips the team to scale hiring, pursue regulatory clearances, and finalize go-to-market preparations. Feminai ultimately intends to bring its device to global markets as a subscription or device-plus-software service, targeting earlier detection and improved outcomes for women’s health. Prior to the seed round, no additional funding amounts were disclosed.
- LeanCon
Participated · Seed · Dec 2025
LeanCon has built what it calls the world’s first AI-enabled pre-construction engineering team, replacing the months-long bid-planning phase with a data-driven workflow that delivers cost, schedule, logistics and method projections in roughly seven minutes. By automating this historically manual process, the startup claims it can slash typical planning costs of about $2 million to virtually zero while increasing win rates and allowing firms to pursue more projects. The technology is already in use on $650 million worth of development projects in New York, providing early commercial validation. Founded by engineers Ziv Levi and Sapir Tubul, the company’s vision is to rebuild construction planning around AI so project teams can save time, cut costs and secure more bids. With fresh capital, LeanCon plans to accelerate product development and expand market adoption. No revenue figures were disclosed, but the large project pipeline underscores initial traction. The company is positioning itself to become a critical tool for contractors and developers facing tight margins and complex builds.
- No Barrier
Led · Seed · Nov 2025
No Barrier is a San Francisco–based health-tech company building an AI-driven, real-time language interpretation platform for healthcare providers. The software embeds into existing electronic health record (EHR) systems with HIPAA-grade security, giving clinicians instant access to interpretation services for limited-English-proficiency (LEP) patients. Its solution is live in more than 100 healthcare sites across 12 U.S. states, covering hospitals and specialties such as mental health, reproductive care, and pediatrics. By eliminating wait times for translators and preserving patient privacy, the product aims to improve clinical outcomes and operational efficiency. The company generates revenue by selling its platform to health systems and individual providers, though specific revenue figures were not disclosed. With fresh capital, management plans to accelerate product development and broaden commercial deployment. Future initiatives include deeper EHR workflow integrations and expansion to additional specialties and geographies.
- Quack
Participated · Seed · Sep 2025
Quack has built an operating system that turns customer support from a reactive cost center into a proactive growth engine by integrating AI agents directly into existing CRM workflows. The platform allows CX teams to train the agents topic-by-topic—mirroring how a human rep is onboarded—so the bots can tackle complex, contextual queries at scale. Quality-assurance tools cover both AI and human interactions, continuously improving agent performance and reliability. The company says dozens of global brands such as Artlist, Yotpo, WalkMe and Hologram already rely on its technology. With a global presence in Tel Aviv, San Francisco and New York, Quack intends to funnel new capital into U.S. go-to-market efforts and further product innovation. Founded by Nadav Kemper and Aviram Roisman, Quack positions itself to help companies reduce support costs while boosting customer satisfaction.